Abstract
In recent years, paired-agent imaging (PAI) strategies have been explored owing to their ability to yield quantitative in vivo imaging of cell-surface receptors.1 – 3 PAI requires the administration of at least two imaging agents of similar blood and tissue kinetics where one agent is targeted to a biomolecule of interest and one is untargeted (the “control” agent). By measuring the dynamics of the control agent, non-specific accumulation of the targeted agent and variable targeted agent delivery (attributable to the variability of blood flow and vascular permeability among tissues, particularly cancerous tissues) can potentially be accounted for, allowing for more quantitative estimates of the targeted agent’s specific binding through the approximation of a quantity termed the “binding potential” (BP). BP is directly proportional to the concentration of an agent’s biomolecular target,4 and as such, the measurement of this quantity can give critical insight into the disease state and phenotype of a biological tissue. In the context of surgical oncology, BP mapping (compared with targeted agent distribution mapping) may enable improved discrimination between malignant and non-malignant tissue types.5,6
Funding Information
  • National Institutes of Health (R37CA212187)

This publication has 55 references indexed in Scilit: